Skip to Main Content

Paper Details

Understanding Drug Sensitivity and Tackling Resistance in Cancer.
Cancer Res
18
2022
Cancer, cancer, immune, patients, tumor, tumor cell lineages
Author NameAffiliation
Jeffrey W TynerKnight Cancer Institute, Oregon Health & Science University
Jeffrey W TynerOregon Health & Science University
Brian Van NessUniversity of Minnesota
Joshi J AlumkalRogel Cancer Center, University of Michigan ann arbor
Trever G BivonaUniversity of California san francisco
Trever G BivonaHelen Diller Family Comprehensive Cancer Center, University of California san francisco
Trever G BivonaUniversity of California san francisco
Keith Syson ChanCedars-Sinai Samuel Oschin Comprehensive Cancer Institute
Keith Syson ChanCedars-Sinai Medical Center
Brian J DrukerKnight Cancer Institute, Oregon Health & Science University
Brian J DrukerOregon Health & Science University
Peter S NelsonUniversity of Washington
Peter S NelsonFred Hutchinson Cancer Research Center
Peter S NelsonUniversity of Washington
Peter S NelsonFred Hutchinson Cancer Research Center
Charles L SawyersMemorial Sloan Kettering Cancer Center
Charles L SawyersHoward Hughes Medical Institute
Christopher D WilleyUniversity of Alabama at Birmingham
Christopher D WilleyUniversity of Alabama at Birmingham
  • 1 - 19

Datasets

Release 1.2